Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Branded Generics Market Through 2029?

The market size for research-grade proteins has seen an exceptional surge over the past few years. The market will move from a value of $1.11 billion in 2024, escalating to $1.33 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 20.4%. The upward trend during the historical period can be sourced back to factors such as the rising number of research studies, increased research and development undertakings in the pharmaceutical and biotechnology fields, increasing demand for tailor-made medicine, elevated investments by governmental bodies and sundry academic institutions, and the strategic mergers and associations.

The market size of research-grade proteins is anticipated to experience a swift expansion over the next few years. The anticipated growth will reach “$2.74 billion in 2029 with a compound annual growth rate (CAGR) of 19.7%. The predicted growth during the forecast period is credited to advancements in proteomics research, an increasing number of clinical trials, integration of artificial intelligence and data analytics, application of research-grade proteins in industrial usage, and escalating demand for cutting-edge research tools. Key trends during the forecast period will be the rising awareness of innovative technologies, advancing techniques in the biotechnology industry, developments in proteomics and genomics, widening applications in drug development, and sophisticated research tools in biotechnology and pharmaceutical sectors.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15917&type=smp

What Market Forces Are Driving The Branded Generics Sector In 2025 And Beyond?

The rising incidence of chronic diseases are projected to fuel the expansion of the branded generics market. Chronic diseases, often incurable yet manageable, are persistent in nature. Increasing tobacco consumption, inadequate nutrition, lack of physical activity, and excessive alcohol intake are some factors contributing to the rise of chronic diseases. Globally, consumers prefer branded generics for treating chronic diseases due to their lower price compared to conventional medications. For example, in September 2022, the World Health Organization (WHO) 2022 Highlights reported that 74% of all deaths worldwide, equating to 41 million fatalities, resulted from noncommunicable diseases (NCDs) or chronic diseases. This upsurge in chronic diseases is anticipated to drive the demand for branded generics in the forecast period.

The research-grade proteins market covered in this report is segmented –

1) By Product: Cytokines And Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products

2) By Host Cell: Mammalian Cells, Bacterial Cells, Fungi And Yeast, Insect Cells, Other Host Cells

3) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Other End-Uses

Subsegments:

1) By Cytokines And Growth Factors: Interleukins, Interferons, Colony Stimulating Factors, Erythropoietin, Granulocyte Macrophage Colony-Stimulating Factor

2) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies

3) By Immune Checkpoint Proteins: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

4) By Virus Antigens: HIV Antigens, Hepatitis Antigens, Influenza Antigens, Hepatitis B Antigens

5) By Enzymes: Restriction Enzymes, Proteases, Ligases, Kinases

6) By Recombinant Regulatory Proteins: Transcription Factors, Regulatory Enzymes, Epigenetic Modifiers

7) By Hormones: Insulin, Thyroid Hormones, Growth Hormones, Adrenaline

8) By Other Products: Peptides, Serum Proteins, Antigen-Binding Proteins

What Long-Term Trends Are Likely To Affect The Branded Generics Market?

Leading enterprises in the market for research-grade proteins are working on the creation of Cas9 proteins, with an aim to boost their functionality and usefulness in genome editing and other biotech applications. Cas9 proteins contribute to genome editing by functioning as molecular scissors that can sever DNA at specific points determined by a guide RNA (gRNA). For instance, Thermo Fisher Scientific Inc., a biotechnology firm based in the US, launched an inventive GMP-manufactured Gibco CTS TrueCut Cas9 Protein in April 2022. This high-quality Cas9 protein, compliant with clinical standards and produced under Good Manufacturing Practice (GMP) conditions, is intended for genome editing applications. It offers superior purity and functionality specifically designed for precise CRISPR-based research, thus aiding progress in genetic engineering and therapeutic development.

Which Firms Are Considered Leaders In The Branded Generics Market Space?

Major companies operating in the research-grade proteins market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Bio-Techne, Stemcell Technologies Inc., Miltenyi Biotec, GenScript Biotech Corporation, Sino Biological Inc., ACROBiosystems, OriGene Technologies Inc., RayBiotech Inc., Rockland Immunochemicals Inc., Proteintech Group Inc., Novus Biologicals LLC, Active Motif, Aviva Systems Biology Corporation, StressMarq Biosciences Inc., Abnova Corporation, AnaSpec, Biomatik, Prospec-Tany Technogene Ltd., Cusabio Technology LLC, United States Biological, Laurus Bio, Boster Biological Technology, AMS Biotechnology Europe Ltd (AMSBIO)

https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report

What Role Do Regional Policies And Investments Play In Branded Generics Market Expansion?

North America was the largest region in the research-grade proteins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15917&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model